Lisa M. Kopcho

818 total citations
17 papers, 433 citations indexed

About

Lisa M. Kopcho is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lisa M. Kopcho has authored 17 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lisa M. Kopcho's work include Biochemical and Molecular Research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Computational Drug Discovery Methods (3 papers). Lisa M. Kopcho is often cited by papers focused on Biochemical and Molecular Research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Computational Drug Discovery Methods (3 papers). Lisa M. Kopcho collaborates with scholars based in United States, Australia and India. Lisa M. Kopcho's co-authors include Jovita Marcinkeviciene, Robert A. Copeland, Wenjun Jiang, Gregory Locke, Michael J. Rogers, Mark Kirby, Lawrence G. Hamann, Andrew Slee, Tasir S. Haque and Andrew M. Stern and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Lisa M. Kopcho

17 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa M. Kopcho United States 11 224 105 93 75 66 17 433
Khuraijam Dhanachandra Singh India 14 315 1.4× 60 0.6× 45 0.5× 109 1.5× 83 1.3× 38 685
Nita Patel United States 13 132 0.6× 82 0.8× 307 3.3× 59 0.8× 28 0.4× 23 644
Li Xiao United States 18 396 1.8× 68 0.6× 39 0.4× 28 0.4× 162 2.5× 28 761
Sarah Tomas‐Hernández Spain 7 234 1.0× 56 0.5× 46 0.5× 39 0.5× 28 0.4× 10 418
Shuyuan Zhao United States 13 335 1.5× 152 1.4× 213 2.3× 34 0.5× 28 0.4× 20 543
Ilka Knütter Germany 14 355 1.6× 42 0.4× 499 5.4× 73 1.0× 52 0.8× 16 886
Karan Kapoor United States 15 333 1.5× 20 0.2× 102 1.1× 97 1.3× 51 0.8× 41 663
Ljubica Šuturkova North Macedonia 14 179 0.8× 38 0.4× 57 0.6× 21 0.3× 32 0.5× 52 606
Paul E. Wiedeman United States 13 179 0.8× 184 1.8× 95 1.0× 66 0.9× 15 0.2× 20 437
Ian D. Collier United Kingdom 12 192 0.9× 106 1.0× 235 2.5× 21 0.3× 44 0.7× 19 448

Countries citing papers authored by Lisa M. Kopcho

Since Specialization
Citations

This map shows the geographic impact of Lisa M. Kopcho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Kopcho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Kopcho more than expected).

Fields of papers citing papers by Lisa M. Kopcho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Kopcho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Kopcho. The network helps show where Lisa M. Kopcho may publish in the future.

Co-authorship network of co-authors of Lisa M. Kopcho

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Kopcho. A scholar is included among the top collaborators of Lisa M. Kopcho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Kopcho. Lisa M. Kopcho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Meng, Wei, Leonard P. Adam, Kamelia Behnia, et al.. (2019). Benzothiazole-based compounds as potent endothelial lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(20). 126673–126673. 4 indexed citations
2.
Wurtz, Nicholas R., Andrew Q. Viet, Scott A. Shaw, et al.. (2018). Potent Triazolopyridine Myeloperoxidase Inhibitors. ACS Medicinal Chemistry Letters. 9(12). 1175–1180. 19 indexed citations
3.
Ma, Zhengping, et al.. (2016). Characterization of monoacylglycerol acyltransferase 2 inhibitors by a novel probe in binding assays. Analytical Biochemistry. 501. 48–55. 3 indexed citations
4.
Tebben, Andrew J., Mian Gao, Dianlin Xie, et al.. (2016). Crystal structures of apo and inhibitor-bound TGFβR2 kinase domain: insights into TGFβR isoform selectivity. Acta Crystallographica Section D Structural Biology. 72(5). 658–674. 22 indexed citations
5.
6.
Onorato, Joelle M., Ching-Hsuen Chu, Zhengping Ma, et al.. (2015). Cell-based assay of MGAT2-driven diacylglycerol synthesis for profiling inhibitors: use of a stable isotope-labeled substrate and high-resolution LC/MS. Journal of Lipid Research. 56(3). 747–753. 7 indexed citations
8.
Iben, Lawrence G., Lisa M. Kopcho, Jovita Marcinkeviciene, et al.. (2008). [3H]BMS-599240 — A novel tritiated ligand for the characterization of BACE1 inhibitors. European Journal of Pharmacology. 593(1-3). 10–15. 8 indexed citations
9.
Kopcho, Lisa M., Young B. Kim, Aiying Wang, et al.. (2005). Probing prime substrate binding sites of human dipeptidyl peptidase-IV using competitive substrate approach. Archives of Biochemistry and Biophysics. 436(2). 367–376. 3 indexed citations
10.
Kim, Young B., Lisa M. Kopcho, Mark Kirby, et al.. (2005). Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118). Archives of Biochemistry and Biophysics. 445(1). 9–18. 62 indexed citations
11.
Marcinkeviciene, Jovita, Lisa M. Kopcho, Tao Yang, et al.. (2002). Novel Inhibition of Porcine Pepsin by a Substituted Piperidine. Journal of Biological Chemistry. 277(32). 28677–28682. 9 indexed citations
12.
Haque, Tasir S., Seifu Tadesse, Jovita Marcinkeviciene, et al.. (2002). Parallel Synthesis of Potent, Pyrazole-Based Inhibitors of Helicobacter pylori Dihydroorotate Dehydrogenase. Journal of Medicinal Chemistry. 45(21). 4669–4678. 49 indexed citations
13.
Mallender, William D., Debra Yager, Luisa Onstead, et al.. (2001). Characterization of Recombinant, Soluble β-Secretase from an Insect Cell Expression System. Molecular Pharmacology. 59(3). 619–626. 27 indexed citations
14.
Marcinkeviciene, Jovita, Wenjun Jiang, Lisa M. Kopcho, et al.. (2001). Enoyl-ACP Reductase (FabI) of Haemophilus influenzae: Steady-State Kinetic Mechanism and Inhibition by Triclosan and Hexachlorophene. Archives of Biochemistry and Biophysics. 390(1). 101–108. 28 indexed citations
15.
Copeland, Robert A., Jovita Marcinkeviciene, Tasir S. Haque, et al.. (2000). Helicobacter pylori-selective Antibacterials Based on Inhibition of Pyrimidine Biosynthesis. Journal of Biological Chemistry. 275(43). 33373–33378. 56 indexed citations
16.
Marcinkeviciene, Jovita, Wenjun Jiang, Gregory Locke, et al.. (2000). A Second Dihydroorotate Dehydrogenase (Type A) of the Human Pathogen Enterococcus faecalis: Expression, Purification, and Steady-State Kinetic Mechanism. Archives of Biochemistry and Biophysics. 377(1). 178–186. 27 indexed citations
17.
Marcinkeviciene, Jovita, Michael J. Rogers, Lisa M. Kopcho, et al.. (2000). Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones. Biochemical Pharmacology. 60(3). 339–342. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026